CDK9 Antikörper (AA 322-372)
Kurzübersicht für CDK9 Antikörper (AA 322-372) (ABIN1977649)
Target
Alle CDK9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 322-372
-
Spezifität
- Region between residue 322 and 372 of human CyclinDependent Kinase 9 using the numbering given in entry NP_001252.1 (GeneID 1025).
-
Aufreinigung
- Immunoaffinity purified
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: IF (1:50 - 1:250), IHC, IHC-P (1:100 - 1:500), IP (2 - 10 μg/mg lysate), PLA (1:200 - 1:4000), WB (1:2000 - 1:10000)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Human controls: Breast Carcinoma, Colon Carcinoma, Lung Cancer, Ovarian Carcinoma. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Tris-buffered saline, 0.1 % BSA, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8°C for up to 1 year.
-
Haltbarkeit
- 12 months
-
-
- CDK9 (Cyclin-Dependent Kinase 9 (CDK9))
-
Andere Bezeichnung
- CDK9
-
Hintergrund
-
Name/Gene ID: CDK9
Subfamily: CDC2/CDK
Family: Protein Kinase
Synonyms: CDK9, C-2k, CDC2L4, CDC2-related kinase, Cell division protein kinase 9, Cyclin-dependent kinase 9, CDC2-related protein kinase, PITALRE, TAK, CTK1 -
Gen-ID
- 1025
-
Pathways
- Zellzyklus
Target
-